Pre-ESRD Syndrome in High Risk African Americans
Evaluation of the dipping status of blood pressure (wether blood pressure decreases at night) and renal functional reserve and wether non-dippers (those whose blood pressure does not decrease at night) can be modulated to dippers with potassium treatment...
Brief Summary
Official Title: “Pre-ESRD Syndrome in High Risk African American Young Adults”
Evaluation of the dipping status of blood pressure (wether blood pressure decreases at night) and renal functional reserve and wether non-dippers (those whose blood pressure does not decrease at night) can be modulated to dippers with potassium treatment.
- Study Type: Interventional
- Study Design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Prevention
Detailed Clinical Trial Description
Evaluation of the dipping status of blood pressure (wether blood pressure decreases at night) and renal functional reserve and wether non-dippers (those whose blood pressure does not decrease at night) can be modulated to dippers with potassium treatment.
Intervention(s) in this Clinical Trial
- Drug: Potassium Chloride
Criteria for Participation in this Clinical Trial
- Inclusion Criteria: 18-35, healthy volunteers, African American
- Exclusion Criteria: Active medical conditions, prescription drug therapy other than birth control
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: 35 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: Accepts Healthy Volunteers
Clinical Trial Investigator Information
Lead Investigator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH
Overall Clinical Trial Officials and Contacts
Elizabeth B Ripley, MD Principal Investigator Virginia Commonwealth University
Additional Information
Information obtained from ClinicalTrials.gov on February 12, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00224939
Study ID Number: DK 62714 (terminated)
ClinicalTrials.gov Identifier: NCT00224939
Health Authority: United States: Federal Government
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00224939
